1. Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study. Issue 12 (18th June 2021) Authors: Jackson, Christopher G. C. A.; Hung, Tak; Segelov, Eva; Barlow, Paula; Prenen, Hans; McLaren, Blair; Hung, Noelyn Anne; Clarke, Katriona; Chao, Tsu‐Yi; Dai, Ming‐Shen; Yeh, Hsien‐Tang; Cutler, David L.; Kramer, Douglas; He, Jimmy; Zhi, Jay; Chan, Wing‐Kai; Kwan, Rudolf; Deva, Sanjeev Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 12(2021) Page Start: 4670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis. Issue 3 (16th November 2021) Authors: Yavel, Regina; Overcash, J. Scott; Cutler, David; Fang, Jane; Zhi, Jay Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 3(2022) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors. (10th May 2022) Authors: He, Jimmy; Jackson, Christopher G. C. A.; Deva, Sanjeev; Hung, Tak; Clarke, Katriona; Segelov, Eva; Chao, Tsu‐Yi; Dai, Ming‐Shen; Yeh, Hsien‐Tang; Ma, Wen Wee; Kramer, Douglas; Chan, Wing‐Kai; Kwan, Rudolf; Cutler, David; Zhi, Jay Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 7(2022) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗